Genetics of Behçet's disease: Lessons learned from genomewide association studies

Current Opinion in Rheumatology

Volumn 26, Issue 1, 2014, Pages 56-63

  Gül, Ahmet ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Behcs disease; ERAP1; HLA B; IL 10; IL 23R; MHC Class I

Indexed keywords

AMINOPEPTIDASE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CHEMOKINE RECEPTOR CCR1; ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA B51 ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 23 RECEPTOR; MEDITERRANEAN FEVER PROTEIN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C MEMBER 4; PROTEIN; SPACER DNA; STAT4 PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BEHCET DISEASE; EPISTASIS; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENE TARGETING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETICS; GENOTYPE; HAPLOTYPE; HERITABILITY; HUMAN; INNATE IMMUNITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; NATURAL KILLER CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; SPONDYLOARTHROPATHY; T LYMPHOCYTE;

AMINOPEPTIDASES; BEHCET SYNDROME; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-B51 ANTIGEN; HUMANS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, CCR1; STAT4 TRANSCRIPTION FACTOR; UBIQUITIN-ACTIVATING ENZYMES;

EID: 84890213258     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000003     Document Type: Review

References (45)

1. Gul A, Ohno S. HLA-B-51 and Behcet disease. Ocul Immunol Inflamm 2012; 20:37-43.
2. A comprehensive review of the possible HLA-B-51-related pathogenic mechanisms. 2. Ono S, Aoki K, Sugiura S, et al. Letter: HL-A5 and Behcet's disease. Lancet 1973; 2:1383-1384.
3. Ohno S, Ohguchi M, Hirose S, et al. Close association of HLA-Bw51 with Behcet's disease. Arch Ophthalmol 1982; 100:1455-1458.
4. De Menthon M, Lavalley MP, Maldini C, et al. HLA-B51/B5 and the risk of Behcet's disease: A systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum 2009; 61:1287-1296.
5. Gul A. Genome-wide association studies in Behcet's disease: Expectations and promises. Clin Exp Rheumatol 2011; 29 (4 Suppl. 67):S3-S5.
6. Fei Y, Webb R, Cobb BL, et al. Identification of novel genetic susceptibility loci for Behcet's disease using a genome-wide association study. Arthritis Res Ther 2009; 11:R66.
7. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nat Genet 2010; 42:698-702.
8. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nat Genet 2010; 42:703-706.
9. Hou S, Yang Z, Du L, et al. Identification of a susceptibility locus in STAT4 for Behcet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum 2012; 64:4104-4113.
10. Lee YJ, Horie Y, Wallace GR, et al. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behcet's disease. Ann Rheum Dis 2013; 72:1510-1516.
11. Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B-51 and ERAP1. Nat Genet 2013; 45:202-207.
12. Trynka G, Hunt KA, Bockett NA, et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011; 43:1193-1201.
13. Ricano-Ponce I, Wijmenga C. Mapping of immune-mediated disease genes. Annu Rev Genomics Hum Genet 2013; 14:325-353.
14. Hughes T, Coit P, Adler A, et al. Identification of multiple independent susceptibility loci in the HLA region in Behcet's disease. Nat Genet 2013; 45:319-324.
15. Clop A, Bertoni A, Spain SL, et al. An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element. PLoS One 2013; 8:e71690.
16. Apps R, Qi Y, Carlson JM, et al. Influence of HLA-C expression level on HIV control. Science 2013; 340:87-91.
17. Strange A, Capon F, Spencer CC, et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010; 42:985-990.
18. Evans DM, Spencer CC, Pointon JJ, et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43:761-767.
19. Reeves E, Edwards CJ, Elliott T, et al. Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity. J Immunol 2013; 191:35-43.
20. Maldini C, Lavalley MP, Cheminant M, et al. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: Systematic review and meta-analyses of observational studies. Rheumatology (Oxford) 2012; 51:887-900.
21. Meguro A, Inoko H, Ota M, et al. Genetics of Behcet disease inside and outside the MHC. Ann Rheum Dis 2010; 69:747-754.
22. Park KS, Park JS, Nam JH, et al. HLA-E-0101 and HLA-G-010101 reduce the risk of Behcet's disease. Tissue Antigens 2007; 69:139-144.
23. Kang EH, Park JW, Park C, et al. Genetic and nongenetic factors affecting the visual outcome of ocular Behcet's disease. Hum Immunol 2013; 74:1363- 1367.
24. Kurata R, Nakaoka H, Tajima A, et al. TRIM39 and RNF39 are associated with Behcet's disease independently of HLA-B -51 and -A -26. Biochem Biophys Res Commun 2010; 401:533-537.
25. Gul A, Hajeer AH, Worthington J, et al. Linkage mapping of a novel susceptibility locus for Behcet's disease to chromosome 6p22-23. Arthritis Rheum 2001; 44:2693-2696.
26. Gul A, Hajeer AH, Worthington J, et al. Evidence for linkage of the HLA-B locus in Behcet's disease, obtained using the transmission disequilibrium test. Arthritis Rheum 2001; 44:239-240.
27. Xavier JM, Shahram F, Davatchi F, et al. Association study of IL10 and IL23RIL12RB2 in Iranian patients with Behcet's disease. Arthritis Rheum 2012; 64:2761-2772.
28. Jiang Z, Yang P, HouS, et al. IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis 2010; 69:1325- 1328.
29. Kirino Y, Zhou Q, Ishigatsubo Y, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci USA 2013; 110:8134-8139.
30. Momozawa Y, Mni M, Nakamura K, et al. Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease. Nat Genet 2011; 43:43-47.
31. Hou S, Xiao X, Li F, et al. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behcet's disease susceptibility. Hum Genet 2012; 131:1841-1850.
32. Karasneh J, Gul A, Ollier WE, et al. Whole-genome screening for susceptibility genes in multicase families with Behcet's disease. Arthritis Rheum 2005; 52:1836-1842.
33. Hayashi T, Imai K, Morishita Y, et al. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res 2006; 66:563-570.
34. Sawalha AH, Hughes T, Nadig A, et al. A putative functional variant within the UBAC2 gene is associated with increased risk of Behcet's disease. Arthritis Rheum 2011; 63:3607-3612.
35. Hou S, Shu Q, Jiang Z, et al. Replication study confirms the association between UBAC2 and Behcet's disease in two independent Chinese sets of patients and controls. Arthritis Res Ther 2012; 14:R70.
36. Hou S, Yang P, Du L, et al. SUMO4 gene polymorphisms in Chinese Han patients with Behcet's disease. Clin Immunol 2008; 129:170-175.
37. Park G, Kim HS, Choe JY, et al. SUMO4 C438T polymorphism is associated with papulopustular skin lesion in Korean patients with Behcet's disease. Rheumatol Int 2012; 32:3031-3037.
38. Kamoun M, Ben Dhifallah I, Karray E, et al. Association of small ubiquitin-like modifier 4 (SUMO4) polymorphisms in a Tunisian population with Behcet's disease. Clin Exp Rheumatol 2010; 28 (4 Suppl. 60):S45-S49.
39. Karaca M, Hatemi G, Sut N, et al. The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families. Rheumatology (Oxford) 2012; 51:1053-1060.
40. Reveille JD, Sims AM, Danoy P, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42:123-127.
41. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42:1118-1125.
42. Anderson CA, Boucher G, Lees CW, et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43:246-252.
43. Tsoi LC, Spain SL, Knight J, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012; 44:1341- 1348.
44. Cosan F, Ustek D, Oku B, et al. Association of familial Mediterranean feverrelated MEFV variations with ankylosing spondylitis. Arthritis Rheum 2010; 62:3232-3236.
45. Solovieff N, Cotsapas C, Lee PH, et al. Pleiotropy in complex traits: Challenges and strategies. Nat Rev Genet 2013; 14:483-495.